Marina Pellón-Consunji

Marina joined Ampersand in 2013. Prior to joining Ampersand, she was an Associate Director in Healthcare Investment Banking at UBS where she worked on a number of leveraged buyouts, mergers and acquisitions, and debt and equity financings for middle-market healthcare companies. Marina’s current and past board seats include GeneWerk, Gyros PTI, Protagene, Vibalogics and VIVEbiotech. Marina holds a B.A. with Honors from Wellesley College where she majored in Biological Chemistry and International Relations. After finishing her degree, she worked at biochemistry laboratories at Harvard Medical School.